Abstract
Tuberculosis infections of the central nervous system are a serious and often fatal disease predominantly impacting young children. Having a success rate of approximately 10%, an in silico data mining search generated 23 analogs to isoniazid, which is a first-line tuberculostatic. All analogs retained the hydrazide functional group in addition to configurations including: quinoline, pyridine, indole, quinolin-4-ol, quinoline-2,4-diol, and pyridine-2-one. Studies have shown that brain penetration is optimal when polar surface area is less than 90 A2. Sixteen of generated analogs have polar surface area less than 70 A2 (drugs 1, 2, 3, 4, 5, 6, 8, 11, 13, 14, 15, 16, 18, 19, 22, and 23) and six analogs have values between 70 A2 to 90 A2 (drugs 7, 9, 10, 12, 17, 21). All agents showed zero violations of the Rule of 5 which indicates favorable druglikeness. The aqueous solubility, formula weight, molecular volume, polar surface area, and Log P properties are determined. Pattern recognition analysis such as hierarchical cluster analysis, discriminate analysis, and ANOSIM identified underlying relationships among these 24 drugs that is based upon important pharmaceutical properties. Global resurgence of tuberculosis and the rapid emergence of multidrug resistant tuberculosis underscore the importance of the development of new tuberculostatic drugs.
Keywords: Tuberculostatic, mycobacterium tuberculosis, isoniazid, tuberculosis
Anti-Infective Agents
Title:Tuberculostatic Drugs Targeting Infections of the Central Nervous System
Volume: 10 Issue: 2
Author(s): Ronald Bartzatt
Affiliation:
Keywords: Tuberculostatic, mycobacterium tuberculosis, isoniazid, tuberculosis
Abstract: Tuberculosis infections of the central nervous system are a serious and often fatal disease predominantly impacting young children. Having a success rate of approximately 10%, an in silico data mining search generated 23 analogs to isoniazid, which is a first-line tuberculostatic. All analogs retained the hydrazide functional group in addition to configurations including: quinoline, pyridine, indole, quinolin-4-ol, quinoline-2,4-diol, and pyridine-2-one. Studies have shown that brain penetration is optimal when polar surface area is less than 90 A2. Sixteen of generated analogs have polar surface area less than 70 A2 (drugs 1, 2, 3, 4, 5, 6, 8, 11, 13, 14, 15, 16, 18, 19, 22, and 23) and six analogs have values between 70 A2 to 90 A2 (drugs 7, 9, 10, 12, 17, 21). All agents showed zero violations of the Rule of 5 which indicates favorable druglikeness. The aqueous solubility, formula weight, molecular volume, polar surface area, and Log P properties are determined. Pattern recognition analysis such as hierarchical cluster analysis, discriminate analysis, and ANOSIM identified underlying relationships among these 24 drugs that is based upon important pharmaceutical properties. Global resurgence of tuberculosis and the rapid emergence of multidrug resistant tuberculosis underscore the importance of the development of new tuberculostatic drugs.
Export Options
About this article
Cite this article as:
Bartzatt Ronald, Tuberculostatic Drugs Targeting Infections of the Central Nervous System, Anti-Infective Agents 2012; 10 (2) . https://dx.doi.org/10.2174/2211362611208020087
DOI https://dx.doi.org/10.2174/2211362611208020087 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
Call for Papers in Thematic Issues
An Overview of Drugs for Multiple Targets and Variants of SARS-CoV-2 Through Artificial Intelligence, Machine Learning, Deep Learning, and Experimental Analysis
The emergence and rapid evolution of SARS-CoV-2 variants have posed significant challenges in the ongoing fight against the COVID-19 pandemic. The development of effective treatments for multiple viral targets and variants demands innovative approaches, including artificial intelligence (AI), machine learning (ML), and deep learning (DL) techniques. This special issue aims ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antibacterial Action of Mixed-ligand Imidazole - Phenanthroline Copper Complex
Anti-Infective Agents Current Research on Opioid Receptor Function
Current Drug Targets Polymer Particulates in Drug Delivery
Current Pharmaceutical Design Synthesis and Antitubercular Activity of New L-serinyl Hydrazone Derivatives
Medicinal Chemistry p-Benzoquinone as a Privileged Scaffold of Pharmacological Significance: A Review
Mini-Reviews in Medicinal Chemistry Acetohydroxyacid Synthase: A Target for Antimicrobial Drug Discovery
Current Pharmaceutical Design In Silico Identification of Human miR 3654 and its Targets Revealed its Involvement in Prostate Cancer Progression
MicroRNA Dual-acting of Hybrid Compounds - A New Dawn in the Discovery of Multi-target Drugs: Lead Generation Approaches
Current Topics in Medicinal Chemistry Mucosal Adjuvants
Current HIV Research Development of New Therapeutics to Meet the Current Challenge of Drug Resistant Tuberculosis
Current Pharmaceutical Biotechnology Dynamic Role of Macrophage Sub Types on Development of Atherosclerosis and Potential Use of Herbal Immunomodulators as Imminent Therapeutic Strategy
Cardiovascular & Hematological Agents in Medicinal Chemistry The Common Mycobacterial Antigens and their Importance in the Treatment of Disease
Current Pharmaceutical Design Synthesis of Substituted -N-(5-((7-Methyl-2-Oxo-2H-Chromen-4-yl)- Methyl)-1,3,4-Thiadiazol-2-yl)-Benzamide Derivatives Using TBTU as Coupling Agent and their Evaluation for Anti Tubercular Activity
Letters in Organic Chemistry An Update on Natural Occurrence and Biological Activity of Chromones
Current Medicinal Chemistry Radiolabelled Peptides: Eon in Radiopharmaceutical
Current Radiopharmaceuticals Genetic Polymorphism of Organic Anion and Cation Transporters: Pharmacokinetic and Pharmacodynamic Consequences in Pharmacotherapy
Current Pharmacogenomics Mechanistic Approach to Explore Isoniazid Derivatives as Antitubercular Agents Using KNN-MF Based-QSAR Analysis, Pharmacophore Modeling and Molecular Docking
Current Drug Therapy Tumor Necrosis Factor: How to Make a Killer Molecule Tumor-Specific?
Current Cancer Drug Targets Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification
Medicinal Chemistry Synthetic and Medicinal Prospective of Structurally Modified Curcumins
Current Topics in Medicinal Chemistry